The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 01, 2018

Filed:

Feb. 11, 2015
Applicant:

Macau University of Science and Technology, Macau, MO;

Inventors:

Liang Liu, Macao, MO;

Ting Li, Macao, MO;

Kam Wai Wong, Macao, MO;

Zhihong Jiang, Macao, MO;

Hua Zhou, Macao, MO;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/027 (2006.01); C12N 15/00 (2006.01); A61K 49/00 (2006.01); G01N 33/573 (2006.01); A61K 31/70 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0278 (2013.01); A61K 49/0008 (2013.01); G01N 33/573 (2013.01); A01K 2207/12 (2013.01); A01K 2227/105 (2013.01); A01K 2267/01 (2013.01); A01K 2267/0368 (2013.01); G01N 33/574 (2013.01); G01N 2333/91215 (2013.01); G01N 2800/102 (2013.01); G01N 2800/44 (2013.01);
Abstract

The present invention provides an in vivo platform for identifying and determining therapeutic or prophylactic activity of test compounds in delay-type hypersensitivity (DTH) and other inflammatory or cancerous diseases mediated by activation of IKK-βmutants. The in vivo platform of the present invention is a non-human transgenic mammal, e.g., a mouse model, with a site directed mutagenesis at a cysteine residue replaced by alanine in IKK-β protein kinase. The site directed mutagenesis is introduced by a specially designed targeting vector containing a transversion in exon 3 of the Ikbkb genes encoding the IKK-β. The present invention also provides methods for generating the transgenic mammal and for determining and identifying compounds that can inhibit activation of IKK-βmutants.


Find Patent Forward Citations

Loading…